Inhibition of neutrophil elastase by recombinant human proteinase inhibitor 9

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1451, Issue 2-3, 1999, Pages 233-241

  Dahlen, Jeffrey R ^a   Foster, Donald C ^b   Kisiel, Walter ^a,b  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b ZYMOGENETICS INC   (United States)

Author keywords

Neutrophil elastase; Proteinase inhibitor 9; Serpin

Indexed keywords

AMINO ACID; CYSTEINE; GLUTATHIONE; GRANZYME B; LEUKOCYTE ELASTASE; OVALBUMIN; PROTEINASE INHIBITOR; RECOMBINANT PROTEIN; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR;

AMINO TERMINAL SEQUENCE; ARTICLE; ENZYME INHIBITION; HUMAN; HUMAN CELL; KINETICS; LUNG; LYMPHOCYTE; NONHUMAN; PLACENTA; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

BINDING SITES; GRANZYMES; KINETICS; LEUKOCYTE ELASTASE; PROTEINS; RECOMBINANT PROTEINS; SERINE ENDOPEPTIDASES; SERPINS;

EID: 0032752774     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4889(99)00095-6     Document Type: Article

References (44)

1. Boutten A., Dehoux M.S., Seta N., Ostinelli J., Venembre P., Crestani B., Dombret M.-C., Durand G., Aubier M. Compartmentalized IL-8 and elastase release within human lung in unilateral pneumonia. Am. J. Respir. Crit. Care Med. 153:1996;336-342.
2. Fujita J., Yamadori I., Takigawa K., Miyawaki H., Yamaji Y., Takahara J. Distribution of human neutrophil elastase in diffuse alveolar damage and pneumonia in case of neonatal sepsis. Respir. Med. 89:1995;505-507.
3. Stockley R.A., Hill S.L., Burnett D. Proteinases in chronic lung infection. Ann. New York Acad. Sci. 624:1991;257-266.
4. Petty T.L. Protease mechanisms in the pathogenesis of acute lung injury. Ann. New York Acad. Sci. 624:1991;267-277.
5. Rennard S.I., Rickard K., Beckmann J.D., Huerta G., Koyama S., Robbins R.A., Romberger D., Spurzem J., Thompson A.B. Protease injury in airways disease. Ann. New York Acad. Sci. 624:1991;278-285.
6. Nadel J.A. Protease actions on airway secretions. Relevance to cystic fibrosis. Ann. New York Acad. Sci. 624:1991;286-296.
7. Smith D.L., Deshazo R.D. Bronchoalveolar lavage in asthma: an update and perspective. Am. Rev. Respir. Dis. 148:1993;523-532.
8. Sinha S., Watorek W., Karr S., Giles J., Bode W., Travis J. Primary structure of human neutrophil elastase. Proc. Natl. Acad. Sci. USA. 84:1987;2228-2232.
9. Plow E.F. Leukocyte elastase release during blood coagulation. A potential mechanism for activation of the alternative fibrinolytic pathway. J. Clin. Invest. 69:1982;564-572.
10. Vender R.L. Therapeutic potential of neutrophil elastase inhibition in pulmonary disease. J. Invest. Med. 44:1996;531-539.
11. 1-antitrypsin with porcine trypsin. Biochemistry. 17:1978;392-400.
12. Wilczynska M., Fa M., Ohlsson P.-I., Ny T. The inhibition mechanism of serpins. Evidence that the mobile reactive center loop is cleaved in the native protease-inhibitor complex. J. Biol. Chem. 270:1995;29652-29655.
13. 2 region of serpins is critical for proteinase inhibition and complex stability. Biochemistry. 36:1997;9562-9570.
14. D.W. Gold, Neutrophil kinetics: Production, distribution, and fate of neutrophils, in: W.J. Williams, E. Beutler, A.J. Erslev, M.A. Lichtman (Eds.), Hematology, McGraw-Hill Publications, Minneapolis, MN, 1983, pp. 759-765.
15. Seemuller U., Arnhold M., Fritz H., Wiedenmann K., Machleidt W., Heinzel R., Appelhans H., Gassen H.-G., Lottspeich F. The acid-stable proteinase inhibitor of human mucous secretion (HUSI-I, antileukoprotease). Complete amino acid sequence as revealed by protein and cDNA sequencing and structural homology to whey proteins and Red Sea turtle proteinase inhibitor. FEBS Lett. 199:1986;43-48.
16. Thompson R.C., Ohlsson K. Isolation, properties and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc. Natl. Acad. Sci. USA. 83:1986;6692-6696.
17. Wiedow O., Schroder J.-M., Gregory H., Young J.A., Christophers E. Elafin: an elastase-specific inhibitor of human skin: Purification, characterization, and complete amino acid sequence. J. Biol. Chem. 263:1990;14791-14795.
18. Molmenti E.P., Ziambaras T., Perlmutter D.H. Evidence for an acute phase response in human intestinal epithelial cells. J. Biol. Chem. 268:1993;14116-14124.
19. 1-proteinase inhibitor by human lung-derived epithelial cells. J. Biol. Chem. 272:1997;8250-8255.
20. Remold-O'Donnell E., Nixon J.C., Rose R.M. Elastase inhibitor. Characterization of the human elastase inhibitor molecule associated with monocytes, macrophages and neutrophils. J. Exp. Med. 169:1989;1071-1086.
21. Thomas R.M., Nauseef W.M., Iyer S.S., Petersen M.W., Stone P.J., Clark R.A. A cytosolic inhibitor of human neutrophil elastase and cathepsin G. J. Leukocyte Biol. 50:1991;568-579.
22. Remold-O'Donnell E., Chin J., Alberts M. Sequence and molecular characterization of human monocyte/neutrophil elastase inhibitor. Proc. Natl. Acad. Sci. USA. 89:1992;5635-5639.
23. Sallenave J.-M., Marsden M.D., Ryle A.P. Isolation of elafin and elastase-specific inhibitor (ESI) from bronchial secretions. Evidence of sequence homology and immunological cross-reactivity. Biol. Chem. Hoppe-Seyler. 373:1992;27-33.
24. Sprecher C.A., Morgenstern K.A., Mathewes S., Dahlen J.R., Schrader S.K., Foster D.C., Kisiel W. Molecular cloning, expression, and partial characterization of two novel members of the ovalbumin family of serine proteinase inhibitors. J. Biol. Chem. 270:1995;29854-29861.
25. Sun J., Bird C., Sutton V., McDonald L., Coughlin P.B., DeJong T.A., Trapani J.A., Bird P. A cytosolic granzyme B inhibitor related to the viral apoptotic regulator cytokine response modifier A is present in cytotoxic lymphocytes. J. Biol. Chem. 271:1996;27802-27809.
26. Dahlen J.R., Foster D.C., Kisiel W. Human proteinase inhibitor 9 (PI9) is a potent inhibitor of subtilisin. Biochem. Biophys. Res. Commun. 238:1997;329-333.
27. Chase T., Shaw E. Titration of trypsin, plasmin, and thrombin with p-nitrophenyl p′-guanidobenzoate HCl. Methods Enzymol. 19:1970;20-27.
28. Chase T., Shaw E. Comparison of the esterase activities of trypsin, plasmin, and thrombin on guanidobenzoate esters. Titration of the enzymes. Biochemistry. 8:1967;2212-2224.
29. Morrison J.F., Walsh C.T. The behavior and significance of slow-binding enzyme inhibitors. Adv. Enzymol. 61:1988;201-301.
30. Cha S. Tight-binding inhibitors. I. Kinetic behavior. Biochem. Pharmacol. 24:1975;2177-2185.
31. 2-antiplasmin as a model inhibitor. Biochemistry. 30:1991;979-986.
32. Tian W.-X., Tsou C.-L. Determination of the rate constant of enzyme modification by measuring the substrate reaction in the presence of the modifier. Biochemistry. 21:1982;1028-1032.
33. Morrison J.F. The slow-binding and slow, tight-binding inhibition of enzyme-catalyzed reactions. Trends Biochem. Sci. 7:1982;102-105.
34. Shapiro R., Riordan J.F. Inhibition of angiotensin converting enzyme: dependence on chloride. Biochemistry. 23:1984;5234-5240.
35. Monkovic D.D., Tracy P.B. Activation of human factor V by factor Xa and thrombin. Biochemistry. 29:1990;1118-1128.
36. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
37. Dahlen J.R., Foster D.C., Kisiel W. Expression, purification and inhibitory properties of human proteinase inhibitor 8. Biochemistry. 36:1997;14874-14882.
38. Quan L.T., Caputo A., Bleackley R.C., Pickup D.J., Salvesen G.S. Granzyme B is inhibited by the cowpox viral serpin cytokine response modifier A. J. Biol. Chem. 270:1995;10377-10379.
39. Travis J., Salvesen G.S. Human plasma proteinase inhibitors. Annu. Rev. Biochem. 52:1983;655-709.
40. Dubin A. A polyvalent proteinase inhibitor from horse blood leukocyte cytosol. Isolation, purification and some molecular parameters. Eur. J. Biochem. 73:1977;429-435.
41. Potempa J., Shieh B.-H., Travis J. Alpha-2-antiplasmin: a serpin with two separate but overlapping reactive sites. Science. 241:1988;699-700.
42. Riewald M., Schleef R.R. Human cytoplasmic antiproteinase neutralizes rapidly and efficiently chymotrypsin and trypsin-like proteases utilizing distinct reactive site residues. J. Biol. Chem. 271:1996;14526-14532.
43. Dahlen J.R., Foster D.C., Kisiel W. The inhibitory specificity of human proteinase inhibitor 8 is expanded through the use of multiple reactive site residues. Biochem. Biophys. Res. Commun. 244:1998;172-177.
44. Dahlen J.R., Jean F., Thomas G., Foster D.C., Kisiel W. Inhibition of soluble recombinant furin by human proteinase inhibitor 8. J. Biol. Chem. 273:1998;1851-1854.